Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Actinium Pharmaceuticals Inc (NYSE American:ATNM)

0.59
Delayed Data
As of 12:31pm ET
 -0.01 / -1.67%
Today’s Change
0.57
Today|||52-Week Range
2.15
-32.57%
Year-to-Date
No recent news for Actinium Pharmaceuticals Inc.

Today’s Trading

Previous close0.60
Today’s open0.59
Day’s range0.58 - 0.59
Volume155,489
Average volume (3 months)494,159
Market cap$48.0M
Dividend yield--
Data as of 12:31pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+9.09%
Earnings growth (this year)-6.00%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.86

Competitors

 Today’s
change
Today’s
% change
AGLEAeglea Bio Therapeut...+0.02+0.69%
EGLTEgalet Corp+0.02+1.80%
JNPJuniper Pharmaceutic...-0.05-1.11%
GNMXAevi Genomic Medicin...+0.01+0.75%
Data as of 12:45pm ET, 08/18/2017

Financials

Last reporting dateAugust 14, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$0.00
Annual profit (last year)-$24.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Sandesh Seth
Chief Financial &
Accounting Officer
Steve Oloughlin
Corporate headquarters
New York, New York

Forecasts